Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Enzo Biochem	Progenity	Exagen	Centogene	OpGen
Symbol	NYSE:ENZ	NASDAQ:PROG	NASDAQ:XGN	NASDAQ:CNTG	NASDAQ:OPGN
Price Information
Current Price	$2.90	$3.09	$15.50	$9.75	$2.42
52 Week Range	N/A	Buy	Buy	Buy	Buy
MarketRank™
Overall Score	0.7	1.8	1.7	1.2	1.3
Analysis Score	0.0	3.3	3.5	3.5	3.5
Community Score	2.5	3.3	3.3	2.6	2.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	1.7	0.8	0.0	0.0
Earnings & Valuation Score	0.0	0.6	0.6	0.0	0.6
Analyst Ratings
Consensus Recommendation	N/A	Buy	Buy	Buy	Buy
Consensus Price Target	N/A	$8.60	$24.40	$18.67	$5.50
% Upside from Price Target	N/A	178.32% upside	57.42% upside	91.45% upside	127.27% upside
Trade Information
Market Cap	$139.86 million	$188.87 million	$196.39 million	$193.65 million	$92.60 million
Beta	0.89	N/A	N/A	-2.25	-0.44
Average Volume	1,019,799	498,155	62,969	58,105	8,785,698
Sales & Book Value
Annual Revenue	$76.02 million	N/A	$40.39 million	$54.64 million	$3.50 million
Price / Sales	1.84	N/A	4.86	3.54	26.46
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$1.22 per share	N/A	$4.43 per share	$3.32 per share	$0.77 per share
Price / Book	2.38	N/A	3.50	2.94	3.14
Profitability
Net Income	$-28,520,000.00	N/A	$-12,040,000.00	$-23,360,000.00	$-12,450,000.00
EPS	N/A	N/A	($8.46)	($1.46)	($6.90)
Trailing P/E Ratio	N/A	0.00	N/A	N/A	N/A
Forward P/E Ratio	∞	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	-24.36%	N/A	-39.49%	N/A	-586.99%
Return on Equity (ROE)	-27.05%	N/A	-29.10%	N/A	-154.05%
Return on Assets (ROA)	-14.76%	N/A	-17.88%	N/A	-68.88%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.08%	N/A	0.55%	0.01%	1.10%
Current Ratio	2.09%	1.07%	12.77%	1.92%	1.74%
Quick Ratio	1.85%	0.95%	12.77%	1.71%	1.39%
Ownership Information
Institutional Ownership Percentage	60.38%	17.08%	29.21%	15.80%	2.29%
Insider Ownership Percentage	9.40%	80.60%	48.90%	N/A	0.36%
Miscellaneous
Employees	408	635	181	440	38
Shares Outstanding	48.23 million	60.34 million	12.67 million	19.86 million	38.27 million
Next Earnings Date	6/14/2021 (Estimated)	6/17/2021 (Estimated)	5/11/2021 (Confirmed)	6/21/2021 (Estimated)	5/6/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	OpGen : Corporate Presentation (PDF) - Marketscreener.com marketscreener.com - May 2 at 6:33 PM
	Global Outbounding Service Market 2020-2025 (Impact of Covid-19) \| OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, OpenMoves, etc. - Clark County Blog clarkcountyblog.com - May 1 at 9:18 AM
	Global Outbound Marketing Service Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, etc. - Clark County Blog clarkcountyblog.com - April 30 at 9:00 AM
	OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time - GlobeNewswire globenewswire.com - April 29 at 8:33 AM
	OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time finance.yahoo.com - April 29 at 8:33 AM
	OpGen Inc (OPGN) has gained 5.22% Tuesday In Premarket Trading - InvestorsObserver investorsobserver.com - April 27 at 5:34 PM
	Global Outbound Marketing Services Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, CIENCE, WebiMax, BlueFocus, RightHello, etc. - Clark County Blog clarkcountyblog.com - April 27 at 12:34 PM
	Global Marketing Automation Consulting Services Market 2021 Analysis By Growth Trends And Forecast 2028: LeadMD, Perkuto, OpGen Media, Couch & Associates, Measured Results Marketing, etc. - Clark County Blog clarkcountyblog.com - April 27 at 7:33 AM
	OpGen (OPGN) Stock Is Up Today in Pre-Hours Trade, Why? - Market Globalist marketglobalist.com - April 27 at 7:33 AM
	Digital Marketing Service Market Outlook: Big Expectations to Watch For OpenMoves, WebiMax, OpGen Media - Clark County Blog clarkcountyblog.com - April 26 at 5:18 AM
	Outbound Market Impressive Gains including key players OpGen Media, CIENCE, WebiMax, BlueFocus – Clark County Blog - Clark County Blog clarkcountyblog.com - April 21 at 7:55 AM
	OpGen, Inc. - Consensus Indicates Potential 184.1% Upside - DirectorsTalk Interviews directorstalkinterviews.com - April 19 at 6:32 PM
	OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections - BioSpace biospace.com - April 19 at 8:31 AM
	OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - Yahoo Finance finance.yahoo.com - April 14 at 6:13 AM
	OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in ... apnews.com - April 13 at 2:56 PM
	Outbound Marketing Service Market May See a Big Move \| OpGen Media, Revenue River, Disruptive Advertising – FLA News - FLA News flanewsonline.com - April 12 at 6:25 PM
	OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - BioSpace biospace.com - April 12 at 8:24 AM
	OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients finance.yahoo.com - April 12 at 8:24 AM
	OpGen Inc (OPGN) Down 3.68% in Premarket Trading - InvestorsObserver investorsobserver.com - April 9 at 12:06 PM
	Should Diagnostics & Research Stock OpGen Inc (OPGN) Be in Your Portfolio Tuesday? - InvestorsObserver investorsobserver.com - March 31 at 12:20 AM
	OPGEN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) - marketscreener.com marketscreener.com - March 30 at 9:19 AM
	Form 10-K OPGEN INC For: Dec 31 - StreetInsider.com streetinsider.com - March 30 at 9:19 AM
	OpGen, Inc. (NASDAQ:OPGN): Why Investors Shouldn’t Ditch OPGN stock in 2021 marketingsentinel.com - March 29 at 6:08 PM
	Global Email Market Estimation 2021-2026 Analysis by Key Players like OpGen Media, Cience, RightHello, WebiMax, LeadMD, InboundLabs, etc. \| Affluence - The Market Eagle themarketeagle.com - March 29 at 1:07 PM
	CBS Streaming on Paramount+ - Yahoo Entertainment yahoo.com - March 27 at 6:51 PM

Date	Company	Brokerage	Action
3/21/2021	Progenity	Robert W. Baird	Reiterated Rating
2/8/2021	Progenity	Wells Fargo & Company	Downgrade
1/14/2021	Progenity	Piper Sandler	Lower Price Target
11/10/2020	Progenity	Raymond James	Lower Price Target
10/23/2020	Progenity	BTIG Research	Initiated Coverage
4/21/2021	Exagen	Canaccord Genuity	Initiated Coverage
3/17/2021	Exagen	Cowen	Boost Price Target
3/8/2021	Exagen	KeyCorp	Boost Price Target
11/11/2020	Exagen	William Blair	Reiterated Rating
6/1/2020	Exagen	Cantor Fitzgerald	Initiated Coverage
12/16/2020	Centogene	SVB Leerink	Reiterated Rating
11/5/2020	Centogene	Credit Suisse Group	Initiated Coverage
10/7/2020	Centogene	Kempen & Co	Initiated Coverage
12/2/2019	Centogene	Evercore ISI	Initiated Coverage
3/15/2021	OpGen	HC Wainwright	Reiterated Rating
3/8/2021	OpGen	Alliance Global Partners	Boost Price Target
9/9/2019	OpGen	Aegis	Set Price Target

(Data available from 5/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources